LL6026-0
APOE Interpretations
- Answer list
- LL6026-0
- Answers
- 6
Answers
| Answer | Code | Score |
|---|---|---|
| The E2/E2 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32571-4 | |
| The E2/E3 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32572-2 | |
| The E3/E3 combination of ApoE isoforms is the most common and is considered average risk with a 1.0 odds ratio for the development of Alzheimer's disease. | LA32573-0 | |
| The E2/E4 combination of ApoE isoforms is considered higher risk with a 2.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32574-8 | |
| The E3/E4 combination of ApoE isoforms is considered higher risk with a 3.2 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32575-5 | |
| The E4/E4 combination of ApoE isoforms is considered high risk with a 14.9 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3). | LA32576-3 |
Used by 1 tests
| LOINC |
|---|
| 98484-9 |